Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells 14,500,002 Shares

Key Points

• Major shareholder Robert Williams Jr. sold 14.5 million Aveanna Healthcare shares at an average price of $11.50, generating approximately $166.75 million. The transaction was disclosed in an SEC filing.
• Aveanna reported quarterly EPS of $0.22, beating estimates of $0.17, while revenue of $670.48 million exceeded the $638.61 million consensus forecast.
• Analyst sentiment remains broadly positive, with the stock carrying a “Moderate Buy” consensus rating and an average price target of $12.89; shares recently traded at $13.70 after reaching a 52-week high of $13.98.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) major shareholder Robert Williams, Jr. sold 14,500,002 shares of Aveanna Healthcare stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $166,750,023.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.

Aveanna Healthcare Price Performance

Shares of AVAH traded up $0.54 during mid-day trading on Monday, hitting $13.70. The company's stock had a trading volume of 5,371,630 shares, compared to its average volume of 1,804,159. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47. Aveanna Healthcare Holdings Inc. has a 1-year low of $5.93 and a 1-year high of $13.98. The firm has a market capitalization of $2.99 billion, a P/E ratio of 11.14, a P/E/G ratio of 0.92 and a beta of 1.90. The firm has a 50-day simple moving average of $9.58 and a 200 day simple moving average of $7.92.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last released its earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%.The company had revenue of $670.48 million during the quarter, compared to the consensus estimate of $638.61 million. Analysts predict that Aveanna Healthcare Holdings Inc. will post 0.68 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently weighed in on AVAH. Truist Financial upped their target price on Aveanna Healthcare from $11.00 to $15.00 and gave the company a "hold" rating in a report on Monday. Stephens upgraded shares of Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and boosted their price objective for the stock from $10.00 to $11.00 in a research report on Friday, May 15th. Weiss Ratings reissued a "hold (c+)" rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. Wall Street Zen downgraded shares of Aveanna Healthcare from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 15th. Finally, Barclays lifted their target price on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the stock an "overweight" rating in a research report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $12.89.

Aveanna Healthcare News Summary

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Royal Bank of Canada raised its price target for Aveanna Healthcare from $10 to $16 and upgraded the stock to “outperform.” The new target implies additional upside from recent trading levels, providing a bullish signal for AVAH. Benzinga analyst price-target report
• Neutral Sentiment: Truist Financial increased its price target from $11 to $15 but maintained a “hold” rating. The higher valuation suggests improved expectations, while the unchanged rating indicates the firm does not see a compelling reason to become more bullish after the stock’s recent advance. Benzinga analyst price-target report
• Negative Sentiment: Several insiders sold a combined 320,000 shares at an average price of $11.50, generating approximately $3.68 million. CEO Jeff Shaner sold 90,000 shares, director Rodney D. Windley sold 180,000, and insider Edwin C. Reisz sold 50,000. Each retained a substantial stake, but the coordinated sales—particularly Windley’s roughly 8% position reduction—could raise concerns about insider confidence or add near-term selling pressure. CEO insider sale filing Director insider sale filing Insider sale filing

Institutional Investors Weigh In On Aveanna Healthcare

Several hedge funds have recently modified their holdings of the company. California State Teachers Retirement System boosted its position in Aveanna Healthcare by 1,351.3% during the second quarter. California State Teachers Retirement System now owns 730,027 shares of the company's stock worth $6,256,000 after acquiring an additional 679,727 shares during the last quarter. Braidwell LP lifted its stake in shares of Aveanna Healthcare by 39.1% during the 2nd quarter. Braidwell LP now owns 3,065,106 shares of the company's stock worth $26,268,000 after purchasing an additional 861,600 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Aveanna Healthcare by 17.6% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 96,956 shares of the company's stock worth $831,000 after purchasing an additional 14,492 shares during the last quarter. Littlejohn & Co. LLC acquired a new stake in shares of Aveanna Healthcare during the second quarter worth $1,846,878,000. Finally, Corient Private Wealth LP purchased a new stake in shares of Aveanna Healthcare in the second quarter valued at $176,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc NASDAQ: AVAH is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna's offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source